Skip to content

The Effect of Animation-Based Education on Menopausal Women's Attitudes, Behaviors, and Screening Test Participation Regarding Breast Cancer

The Effect of Education Provided to Women in Menopause Through Animation on Breast Cancer Attitudes, Behaviors, and Screening Test Participation

Status
Not yet recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07042737
Acronym
Menopause
Enrollment
136
Registered
2025-06-29
Start date
2025-06-20
Completion date
2026-10-20
Last updated
2025-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast Cancer Females, Education Nursing, Menopausal Women, Motivation, Screening Strategy

Keywords

education through animation, menopause, breast cancer, screening test, motivation

Brief summary

The aim of this study was to determine the effect of education provided to women in menopause through animation on their attitudes toward breast cancer, behaviors, and screening test participation. The study will include a total of 136 women in the menopausal period, comprising 68 experimental group participants and 68 control group participants who have applied to the Orduyeri and Kırtepe Family Health Centers affiliated with the Bartın Public Health Institution. Women who agree to participate in the project, which will run from January to August 2025, will receive 40-45 minute training sessions in a suitable room at the ASM. The training sessions will be conducted in groups of 8-12 people. The training content will include information about the purpose, duration, and rules of the training. After providing information about the project, a pre-test will be administered. Through face-to-face interviews, researchers assigned to the project will show animated videos enriched with sound and images via an online program they have prepared. These videos will be 10-12 minutes long, and an interim test will be conducted. Three months after the pre-test, the women participating in the study will be contacted, and a final test will be administered in their own homes. Project data will be collected using the Personal Information Form, Champion Health Belief Scale, and Breast Cancer Awareness Scale. Descriptive statistics, independent sample t-tests, chi-square tests, and repeated measures analysis of variance (ANOVA) tests will be used in the statistical analysis of the project.

Detailed description

Menopause is a stage of life in which women's reproductive functions cease due to a decline in ovarian activity and a corresponding decrease in the hormones produced by the ovaries. Seventy percent of women in menopause experience at least one symptom related to menopause. These symptoms can negatively affect women's daily lives, quality of life, interpersonal relationships, and sexual lives. Additionally, it increases women's risk of health issues such as breast cancer, cardiovascular disease, and obesity. Women's perceptions, attitudes, and behaviors toward menopause determine the methods they use to cope with these symptoms and health issues. Women spend one-third of their lives in menopause and use methods such as lifestyle changes, reflexology, massage, acupressure, and listening to music to cope with menopause symptoms and issues. Animation-based education is extremely important in terms of improving the quality of education and ensuring women's self-confidence and focus. There are studies in the literature that examine the effect of educational programs on breast cancer attitudes, behaviors, and screening test status in order to cope with menopausal symptoms and breast cancer. However, no studies have been found that evaluate educational applications delivered through animation, which is thought to increase the effectiveness of education. Based on this, this study was designed to determine the effect of education delivered through animation to women in menopause on breast cancer attitudes, behaviors, and screening test participation. The study will include a total of 136 women in the menopausal period, comprising 68 experimental group participants and 68 control group participants who have applied to the Orduyeri and Kırtepe Family Health Centers affiliated with the Bartın Public Health Institution. Women who agree to participate in the project, which will run from January to August 2025, will receive 40-45 minute training sessions in a suitable room at the ASM. The training sessions will be conducted in groups of 8-12 people. The training content will include information about the purpose, duration, and rules of the training. After providing information about the project, a pre-test will be administered. Through face-to-face interviews, researchers assigned to the project will show animated videos enriched with sound and images via an online program they have prepared. These videos will be 10-12 minutes long, and an interim test will be conducted. Three months after the pre-test, the women participating in the study will be contacted, and a final test will be administered in their own homes. Project data will be collected using the Personal Information Form, Champion Health Belief Scale, and Breast Cancer Awareness Scale. Descriptive statistics, independent sample t-tests, chi-square tests, and repeated measures analysis of variance (ANOVA) tests will be used in the statistical analysis of the project.

Interventions

BEHAVIORALanimation-based breast cancer education

The animation-based humorous application consists of four videos, each lasting 40-45 minutes, which separately explain the signs and symptoms of breast cancer, self-breast examination, clinical breast examination, and mammography through animation.

No intervention will be applied to the control group.

Sponsors

Inonu University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
DOUBLE (Investigator, Outcomes Assessor)

Masking description

After randomization was performed by an independent researcher, the experimental group and control group were determined by lottery. In addition, the data will be analyzed by S.Ö., a researcher who did not collect the data, using masked data. The experimental and control groups will be assigned as A and B in the analysis program in such a way that S.Ö. will not know which group is which.

Intervention model description

Participants identified by researchers prior to the start of the study were divided into experimental and control groups using a randomization method. Women in the experimental group will receive 40-45 minute training sessions once a week for one week on specified days and times. The training sessions will be conducted in groups of 8-12 people. The content of the training sessions will include information about the purpose, duration, and rules of the training. After the information is provided, a pre-test will be administered. Using the face-to-face interview method, researchers involved in the study will show animated videos enriched with sound and images through an online program they have prepared, lasting 10-12 minutes. A mid-test will be conducted 14 days after the pre-test. Three months after the pre-test, the women participating in the study will be contacted, and a final test will be administered in their own homes.

Eligibility

Sex/Gender
FEMALE
Healthy volunteers
Yes

Inclusion criteria

* Not having been diagnosed with breast cancer, * not performing regular self-examinations (those who performed self-examinations at least once a month were excluded), * not having had a mammogram (those who had a mammogram within the first six months after training were excluded), * not having undergone a clinical breast examination (those who underwent a clinical breast examination within the first 6 months after the training were excluded), * not breastfeeding or being pregnant, being literate, owning a smartphone, * having internet access, * not having uterine abnormalities, * having ovaries, * not having used sex hormones.

Exclusion criteria

* never experiencing menopausal symptoms, * undergoing surgical menopause, * currently or previously using hormonal therapy, * having a psychiatric disorder, * having menstruated in the past year, * incomplete forms, * not fully participating in video-based education programs.

Design outcomes

Primary

MeasureTime frameDescription
menopause symptom scale3 monthThe scale consists of a total of 11 items and 3 subscales. These 3 subscales are called the Somatic Complaints subscale, Psychological Complaints subscale, and Urogenital Complaints subscale. The scale is a 5-point Likert scale. The score obtained from the scale ranges from 0 to 44 points. An increase in the total score obtained from the scale indicates an increase in the severity of menopausal complaints experienced.

Secondary

MeasureTime frameDescription
Champion Health Belief Model Scale3 monthThe scale has eight subscales and consists of 58 items. These are: importance/seriousness, sensitivity, health motivation, benefits and barriers to self-breast examination, self-efficacy, and benefits and barriers to mammography. Scale items are scored on a scale of 1 to 5. The lowest score for all dimensions of the scale is the sum of the lowest scores of the subgroup, and the highest score is the sum of the highest scores of the subgroup. It has been noted that as the score obtained from the scale increases, the subdimensions also increase.
Breast Cancer Awareness Scale3 monthThe scale consists of a total of 13 items, including symptoms (11 items), breast examination frequency (1 item), and age of breast cancer (1 item), to determine the breast cancer awareness scale. There is no cut-off point for the scale. When 5 symptoms are reported, 1 point is awarded; when a woman aged 70 is indicated, 1 point is awarded; and when a monthly breast examination is reported, 1 point is awarded. Incorrect answers receive 0 points. Scoring ranges from 0 to 3. It has been determined that as the score from the scale increases, breast cancer awareness also increases.

Countries

Turkey (Türkiye)

Contacts

Primary ContactSimge Öztürk, Ph.D
simgeozturk2123@gmail.com+905398751788

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026